Portal de Periódicos da CAPES

Comments on nitric oxide in children with asthma, low‐dose oral immunotherapy for cow's milk allergy, and SARS‐Cov‐2 testing in school children

2021; Wiley; Volume: 32; Issue: 4 Linguagem: Inglês

10.1111/pai.13499

1399-3038

Philippe Eigenmann,

Food Allergy and Anaphylaxis Research

Pediatric Allergy and ImmunologyVolume 32, Issue 4 p. 631-634 EDITORIAL Comments on nitric oxide in children with asthma, low-dose oral immunotherapy for cow's milk allergy, and SARS-Cov-2 testing in school children Philippe Eigenmann, Corresponding Author Philippe Eigenmann Editor-in-Chief [email protected] orcid.org/0000-0003-1738-1826 Department of Women-Children-Teenagers, University Hospital of Geneva, Geneva, SwitzerlandSearch for more papers by this author Philippe Eigenmann, Corresponding Author Philippe Eigenmann Editor-in-Chief [email protected] orcid.org/0000-0003-1738-1826 Department of Women-Children-Teenagers, University Hospital of Geneva, Geneva, SwitzerlandSearch for more papers by this author First published: 01 May 2021 https://doi.org/10.1111/pai.13499Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Papadopoulos NG, Aggelides X, Stamataki S, et al. New concepts in pediatric rhinitis. Pediatr Allergy Immunol. 2021; 32: 635-646. 10.1111/pai.13454 Google Scholar 2Peters RL, Krawiec M, Koplin JJ, et al. Update on food allergy. Pediatr Allergy Immunol. 2021; 32: 647-657. 10.1111/pai.13443 PubMedWeb of Science®Google Scholar 3Hedman AM, Kuja-Halkola R, Örtqvist AK, et al. Genetic effects of allergen-specific IgE levels on exhaled nitric oxide in schoolchildren with asthma: The STOPPA twin study. Pediatr Allergy Immunol. 2021; 32: 709-719. 10.1111/pai.13438 Web of Science®Google Scholar 4Bougas N, Just J, Beydon N, et al. Unsupervised trajectories of respiratory/allergic symptoms throughout childhood in the PARIS cohort. Pediatr Allergy Immunol. 2019; 30: 315-324. 10.1111/pai.13027 PubMedWeb of Science®Google Scholar 5Lajunen KT, Malmberg LP, Kalliola S, et al. Predictive value of childhood airway hyper-responsiveness to indirect stimuli: 10-year longitudinal study. Pediatr Allergy Immunol. 2020; 31: 767-773. 10.1111/pai.13248 PubMedWeb of Science®Google Scholar 6Lodge CJ, Lowe AJ, Abramson MJ, et al. Transient childhood wheeze is associated with less atopy in adolescence. Pediatr Allergy Immunol. 2020; 31: 913-919. 10.1111/pai.13304 PubMedWeb of Science®Google Scholar 7de Castro MF, Paciência I, Cavaleiro Rufo J, et al. The inflammatory potential of diet impacts the association between air pollution and childhood asthma. Pediatr Allergy Immunol. 2020; 31: 290-296. 10.1111/pai.13185 PubMedWeb of Science®Google Scholar 8Ninomiya T, Odajima H, Honjo S, et al. Effect of spirometry on exhaled nitric oxide values in asthmatic children. Pediatr Allergy Immunol. 2019; 30: 654-657. 10.1111/pai.13086 PubMedWeb of Science®Google Scholar 9Schoos A-MM, Jelding-Dannemand E, Stokholm J, et al. Single and multiple time-point allergic sensitization during childhood and risk of asthma by age 13. Pediatr Allergy Immunol. 2019; 30: 716-723. 10.1111/pai.13109 PubMedWeb of Science®Google Scholar 10Berti I, Badina L, Cozzi G, et al. Early oral immunotherapy in infants with cow's milk protein allergy. Pediatr Allergy Immunol. 2019; 30: 572-574. 10.1111/pai.13057 PubMedWeb of Science®Google Scholar 11Kauppila TK, Paassilta M, Kukkonen AK, et al. Outcome of oral immunotherapy for persistent cow's milk allergy from 11 years of experience in Finland. Pediatr Allergy Immunol. 2019; 30: 356-362. 10.1111/pai.13025 PubMedWeb of Science®Google Scholar 12Gruzelle V, Juchet A, Martin-Blondel A, et al. Benefits of baked milk oral immunotherapy in French children with cow's milk allergy. Pediatr Allergy Immunol. 2020; 31: 364-370. 10.1111/pai.13216 PubMedWeb of Science®Google Scholar 13Nagakura K-I, Sato S, Miura Y, et al. A randomized trial of oral immunotherapy for pediatric cow's milk-induced anaphylaxis: Heated vs unheated milk. Pediatr Allergy Immunol. 2021; 32: 161-169. 10.1111/pai.13352 CASPubMedWeb of Science®Google Scholar 14Miura Y, Nagakura K, Nishino M, et al. Long-term follow-up of fixed low-dose oral immunotherapy for children with severe cow's milk allergy. Pediatr Allergy Immunol. 2021; 32: 734-741. 10.1111/pai.13442 CASPubMedWeb of Science®Google Scholar 15Naito M, Matsui T, Tagami K, et al. Changes in casein component-specific antibody levels during oral immunotherapy for milk allergy. Pediatr Allergy Immunol. 2020; 31: 421-424. 10.1111/pai.13218 PubMedWeb of Science®Google Scholar 16Brandstetter S, Roth S, Harner S, et al. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak. Pediatr Allergy Immunol. 2020; 31: 841-847. 10.1111/pai.13278 PubMedWeb of Science®Google Scholar 17Matricardi PM, Negro RWD, Nisini R. The first, holistic immunological model of COVID-19: Implications for prevention, diagnosis, and public health measures. Pediatr Allergy Immunol. 2020; 31: 454-470. 10.1111/pai.13271 CASPubMedWeb of Science®Google Scholar 18Lu X, Xiang Y, Du H, et al. SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic. Pediatr Allergy Immunol. 2020; 31: 449-453. 10.1111/pai.13267 PubMedWeb of Science®Google Scholar 19Rothan HA, Byrareddy SN. The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic. Pediatr Allergy Immunol. 2021; 32: 17-22. 10.1111/pai.13361 CASPubMedWeb of Science®Google Scholar 20Brough HA, Kalayci O, Sediva A, et al. Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – The 2020 COVID-19 pandemic: a statement from the EAACI-section on pediatrics. Pediatr Allergy Immunol. 2020; 31: 442-448. 10.1111/pai.13262 CASPubMedWeb of Science®Google Scholar 21Kabesch M. Shielding against SARS-CoV-2 infection is not justified in children with severe asthma. Pediatr Allergy Immunol. 2021; 32: 198. 10.1111/pai.13327 CASPubMedWeb of Science®Google Scholar 22Szépfalusi Z, Schmidthaler K, Sieber J, et al. Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: a cross-sectional study. Pediatr Allergy Immunol. 2021; 32: 762-770. 10.1111/pai.13459 Web of Science®Google Scholar Volume32, Issue4May 2021Pages 631-634 ReferencesRelatedInformation